GHEZZO, SAMUELE
 Distribuzione geografica
Continente #
EU - Europa 171
NA - Nord America 129
AS - Asia 89
OC - Oceania 17
Totale 406
Nazione #
US - Stati Uniti d'America 128
IT - Italia 98
CN - Cina 45
SG - Singapore 33
SE - Svezia 27
AU - Australia 17
RU - Federazione Russa 13
DE - Germania 7
FI - Finlandia 7
NL - Olanda 7
IR - Iran 6
FR - Francia 3
GB - Regno Unito 3
ID - Indonesia 3
BG - Bulgaria 2
IE - Irlanda 2
JP - Giappone 2
CA - Canada 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 406
Città #
Milan 39
Singapore 29
New York 28
Shanghai 22
Ashburn 16
Boardman 16
Rome 10
Moscow 8
Canberra 6
Lawrence 6
Princeton 6
Adelaide 5
Dallas 5
Helsinki 5
Pesaro 4
Bandung 3
Dongen 3
Lissone 3
Sittard 3
Sydney 3
Bari 2
Bologna 2
Cascina 2
Dublin 2
Jiaxing 2
Lappeenranta 2
Naples 2
Pescara 2
Razgrad 2
San Giuseppe Vesuviano 2
Seattle 2
Vigonza 2
Washington 2
Amsterdam 1
Beijing 1
Bergamo 1
Black River Falls 1
Boston 1
Bratislava 1
Council Bluffs 1
Essen 1
Fiorano Modenese 1
Foshan 1
Gunzenhausen 1
Hangzhou 1
Hessisch Oldendorf 1
London 1
Los Angeles 1
Macerata 1
Melbourne 1
Menlo Park 1
Neyagawa 1
Romford 1
San Jose 1
Sant'Agata di Militello 1
Scunthorpe 1
Shenyang 1
Shenzhen 1
Stratford 1
Tokyo 1
Toronto 1
Torrile 1
Treviso 1
Warsaw 1
Wuhan 1
Wuhu 1
Wuxi 1
Totale 280
Nome #
Integrazione di radiomica, Machine/Deep Learning ed istologia come metodo innovativo per la caratterizzazione tumorale utilizzando la tecnica ibrida PET/RM 49
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 47
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 42
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 36
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 35
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 29
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 26
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 26
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 25
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 23
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 22
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 22
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 21
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 16
Radiomics and artificial intelligence 14
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 13
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 12
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 10
Totale 468
Categoria #
all - tutte 4.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 0 0 0 0 6 9 6 4 2 1
2022/202388 14 13 5 8 8 5 7 10 0 12 0 6
2023/2024227 11 12 34 27 15 38 9 18 0 9 19 35
2024/2025125 28 14 40 21 22 0 0 0 0 0 0 0
Totale 468